Metall Zug – Annual General Meeting of Shareholders approves all proposals
|
Metall Zug AG
/ Key word(s): AGMEGM
Media announcement Zug, May 9, 2025 – At the 138th ordinary Annual General Meeting of Metall Zug AG, the shareholders approved all the proposals of the Board of Directors.
A total of 281 shareholders representing 78.17% of the share capital and 92.33% of the votes attended today's 138th Annual General Meeting of Metall Zug AG, which took place at ZUGORAMA in Zug. All proposals of the Board of Directors were approved by a large majority. The Annual General Meeting approved the annual report as well as the annual and consolidated financial statements and the report on non-financial matters (sustainability report) as well as – in the context of a consultative vote – the 2024 compensation report. Furthermore, the shareholders approved the appropriation of the available earnings 2024 as follows: distribution of a cash dividend in the amount of CHF 2.00 (gross) per registered share type A and CHF 20.00 (gross) per registered share type B. The total value of the cash dividend distribution – no distribution will be made on Metall Zug's treasury shares – is expected to be CHF 8,948,580. The amount of CHF 38,925,305 will be carried forward to the new account. The cash dividend is expected to be paid on May 15, 2025. In the context of a consultative vote the shareholders approved the payment of CHF 450,000 (approximately 5% of the dividend amount) charged to the 2025 annual financial statements into the Greenhouse Gas Fund. The funds are earmarked for supporting group-wide sustainability projects that focus on promoting the circular economy, energy efficiency, and CO2 reduction. In this context, Sebastian Hinz (Chief of Staff at Haag-Streit Holding AG) gave an in-depth insight into the project “Circular Economy at Haag-Streit” during his guest speech. Sandrine Zweifel, Deputy Director of the Ophthalmology Clinic at Zurich University Hospital, has been newly elected to the Board of Directors. With this appointment, Metall Zug is emphasizing its increased strategic focus on ophthalmology. The existing members of the Board of Directors Martin Wipfli, Dominik Berchtold, David Dean, Bernhard Eschermann and Claudia Pletscher were re-elected for a further term of office of one year. Martin Wipfli, a Board member since 2010 and Chairman of the Board of Directors of Metall Zug AG since 2019, was confirmed in his role. Furthermore, the Annual General Meeting approved the remuneration for the members of the Board of Directors until the next ordinary General Meeting and the fixed compensation of the Senior Management in the year 2026, both prospectively. The shareholders also retrospectively approved the variable compensation of the Senior Management for the year 2024. The next 139th ordinary Annual General Meeting of Shareholders of Metall Zug AG will presumably take place on Friday, May 8, 2026, in Zug. About the Metall Zug Group
In addition, Metall Zug holds anchor participations in the listed V-ZUG Holding AG (30%), the listed Komax Holding AG (25%) and SteelcoBelimed AG (33%), a joint venture with Miele. The holding company Metall Zug AG is listed in the Swiss Reporting Standard of SIX Swiss Exchange in Zurich (type B registered shares: securities number 3982108, ticker symbol METN). Legal Notes
The expectations expressed in this announcement are based on assumptions. Actual results may vary from those anticipated. This announcement is published in German and English. The German version is binding. Metall Zug AG processes personal data in accordance with its privacy statement available under: https://metallzug.ch/en/privacy.
or: investorrelations@metallzug.ch This announcement is available at https://metallzug.ch/en/media.
End of Media Release |
2134562 09.05.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.